See the retatrutide vendor comparison at /best/retatrutide for current pricing and COA verification
But the FDA declared the shortages over in February based on data from Eli Lilly and Novo Nordisk showing they could meet demand, giving compounders a few months to wind down production
These issues may lessen over time, but are severe enough that many doctors prescribe other drugs during the initial dose escalation phase to mitigate your suffering
Reading Published Dose Ranges Correctly Retatrutides Phase 3 TRIUMPH-1 trial, with topline results reported by Eli Lilly in May 2026, evaluated three target doses 4mg, 9mg, and 12mg weekly with all arms starting at 2mg and escalating in steps every four weeks (2mg 4mg 6mg 9mg 12mg, depending on target arm) rather than starting at the target dose directly
Additionally, in a phase 2 trial targeting type 2 diabetes, retatrutide demonstrated significant improvements in glycemic control and substantial weight reduction, maintaining a safety profile comparable to certain approved GLP-1RAs 8 (Supplementary Table S1)
A COA can tell you the vial contains a peptide of roughly the right mass
:max_bytes(150000):strip_icc()/benefits-of-glutathione-89457_final-01-502464fe91b2444285b0cccf8cb0a33c.png)
